Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Sinopharm Group Co ( (HK:1099) ).
Sinopharm Group Co. Ltd. announced the resignation of Mr. Liu Hongbing as an employee representative supervisor, effective from June 10, 2025. The company expressed gratitude for his contributions, and Mr. Liu confirmed no disagreements with the board, indicating a smooth transition without impact on stakeholders.
The most recent analyst rating on (HK:1099) stock is a Buy with a HK$29.30 price target. To see the full list of analyst forecasts on Sinopharm Group Co stock, see the HK:1099 Stock Forecast page.
More about Sinopharm Group Co
Sinopharm Group Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China, operating in the healthcare industry. It is known for its pharmaceutical distribution and retail services, focusing on providing medical and healthcare products across various markets.
Average Trading Volume: 7,875,795
Technical Sentiment Signal: Sell
Current Market Cap: HK$58.26B
For detailed information about 1099 stock, go to TipRanks’ Stock Analysis page.